We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$25.3B
AUM Growth
+$814M
Cap. Flow
+$613M
Cap. Flow %
2.42%
Top 10 Hldgs %
16.08%
Holding
3,081
New
5
Increased
1,358
Reduced
932
Closed
769

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$31.9M
2
AAPL icon
Apple
AAPL
+$24.9M
3
T icon
AT&T
T
+$21.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.2M
5
BIIB icon
Biogen
BIIB
+$19.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$34M
2
RHT
Red Hat Inc
RHT
+$22.2M
3
HSBC icon
HSBC
HSBC
+$20.3M
4
APC
Anadarko Petroleum
APC
+$19.9M
5
CAJ
Canon, Inc.
CAJ
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 16.76%
3 Healthcare 12.56%
4 Consumer Discretionary 10.05%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PZZA icon
2651
Papa John's
PZZA
$995M
-2,647
Closed -$118K
QNST icon
2652
QuinStreet
QNST
$890M
-4,603
Closed -$73K
QTRX icon
2653
Quanterix
QTRX
$166M
-582
Closed -$20K
QURE icon
2654
uniQure
QURE
$2.93B
-1,068
Closed -$83K
RBB icon
2655
RBB Bancorp
RBB
$446M
-182
Closed -$4K
RBBN icon
2656
Ribbon Communications
RBBN
$373M
-7,255
Closed -$35K
RBCAA icon
2657
Republic Bancorp
RBCAA
$1.93B
-701
Closed -$35K
RCKT icon
2658
Rocket Pharmaceuticals
RCKT
$351M
-1,307
Closed -$20K
RCUS icon
2659
Arcus Biosciences
RCUS
$3.55B
-3,999
Closed -$32K
RDFN
2660
DELISTED
Redfin
RDFN
-5,341
Closed -$96K
RDNT icon
2661
RadNet
RDNT
$4.93B
-2,641
Closed -$36K
RDWR icon
2662
Radware
RDWR
$1.05B
-9,547
Closed -$236K
REI icon
2663
Ring Energy
REI
$315M
-11,577
Closed -$38K
RFL icon
2664
Rafael Holdings
RFL
$104M
-1,015
Closed -$29K
RGNX icon
2665
Regenxbio
RGNX
$648M
-5,204
Closed -$267K
RILY icon
2666
BRC Group Holdings
RILY
$282M
-1,396
Closed -$29K
RM icon
2667
Regional Management Corp
RM
$297M
-303
Closed -$8K
RMTI icon
2668
Rockwell Medical
RMTI
$28M
-7
Closed -$2K
RRGB icon
2669
Red Robin
RRGB
$144M
-4,991
Closed -$153K
RYTM icon
2670
Rhythm Pharmaceuticals
RYTM
$7.25B
-390
Closed -$9K
SA
2671
Seabridge Gold
SA
$2.89B
-8,418
Closed -$114K
SCOR icon
2672
Comscore
SCOR
$112M
-16
Closed -$2K
SD icon
2673
SandRidge Energy
SD
$501M
-5,512
Closed -$38K
SENEA icon
2674
Seneca Foods Class A
SENEA
$1.13B
-77
Closed -$2K
SENS icon
2675
Senseonics Holdings Inc
SENS
$265M
-288
Closed -$12K

Similar funds

Aperio Group's Q3 2019 Portfolio in Review

As of Q3 2019, Aperio Group held 3,081 positions worth $25.3B, up 3.3% from $24.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q3 2019 filing shows 5 new, 1,358 increased, 932 reduced and 769 closed positions. Its largest new stake was Genmab: 211,272 shares worth $4.28M. The largest sale was Pfizer, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q3 2019 buy was Genmab: 211,272 shares worth $4.28M.
  • Aperio Group added most to Microsoft in Q3 2019, an estimated $31.9M increase.
  • Aperio Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $34M.
  • Aperio Group fully exited Red Hat Inc in Q3 2019, selling an estimated $22.2M.
  • Aperio Group's ten largest holdings make up 16% of its $25.3B portfolio in Q3 2019.
  • Aperio Group opened 5 new positions and closed 769 in Q3 2019.
  • Aperio Group's portfolio value rose 3.3% quarter-over-quarter to $25.3B.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.